Nordic Medical Affairs Manager
We are now looking for you that wants to be responsible for the strategic medical development of oncology products in the Nordics and in a progressive entrepreneurial and fast growing operation. You will lead a team of two MSLs, and opportunity to have a key role in impacting the company’s future.
About the role
This post will manage and direct as appropriate the delivery of medical activities with internal and external key stakeholders and healthcare policy makers in accordance with the medical-marketing strategy for commercial products, new indications and pipeline compounds.
Key medical activities include:
Medical plan support and delivery
Leading the medical team
Monitoring and understanding of the relevant therapeutic areas, including :
Comprehensive and up-to-date understanding of all relevant clinical data as well as related matters relevant to
Data and competitive intelligence analysis
Analysis, interpretation and reporting of current environments (regulatory, market access, pharmacovigilance etc), as well as providing support to the relevant teams,
Scientific exchanges with experts (advisory boards, investigator meetings, data presentation and analysis, one-to-one and group discussions etc),
Interactions with relevant external stakeholders
MSL scientific support
Support to Cross-funtional team (Marketing & Sales and marketing teams)
Support to Sponsor-led clinical studies
Investigator initiated study proposal analysis and follow-up,
Attendance at scientifc meetings and congresses
Support of local compliance team & be responsible for marketing material medical validation
Contribute to the commercial success of oncology products in the Nordics by actively participating in strategy development in conjunction with the product manager and Business Unit Manager (Cross-functional team):
Develop medical programs/tactics to meet strategic imperatives of the business
Drive strategy to develop relationships with key opinion leaders
Identify and work with policy makers and key stakeholders to influence strategy and priorities
Increase medical and scientific profile of PFO to internal & external customers
Input to Authorities (reimbursement bodies) from medical perspective
Management of high level technical and scientific support to aid promotion of the company’s products
Management of training for all customer focussed staff to enhance understanding of therapeutic areas and products including :
Medical review of promotional and non-promotional material
Preparation and review of medical and scientific communication
Final medical signatory for Pierre Fabre Ltd
Integration- Nordic & Paris communication
Interventional/Non-Interventional Studies Programme
Managing investigator-driven studies, resources & patient selection in accordance with local laws and procedures
Management of Nordic medical team to develop and maintain local clinical trial portfolio
Quality & Regulatory
Support QRVI in regulatory and quality related matters, including compliance
To ensure regulatory submissions meet the needs of the business and comply with regulatory requirements as well as meeting agreed objectives and timelines
Integration of Corporate SOPs within Nordic processes together with local QRVI
Support QRVI in preparing for authority inspections – GDP, GVP, CV
Identify and evaluate new opportunities in both Oncology and General/Ethical line
About Pierre Fabre
Pierre Fabre Pharma Norden is a dynamic company, looking at growing it’s organisation and footprint in Nordics. Nordic headquarter is located in Stockholm and company is having presence in all Nordic countries.
The history of the Pierre Fabre Group is first and foremost that of one man, a dispensary pharmacist and an enthusiastic entrepreneur. Pierre Fabre grew his dispensary into a pharmaceutical laboratory on an international scale, rooted in his home region and loyal to the humanist values that he always defended.
Originating in the pharmaceutical sector over 50 years ago, Pierre Fabre continuing to develop their pharmaceuticals business, with a desire to provide patients with treatments where oncology is the main priority. Other focus areas are dermatological Rx and consumer health care.
Pierre Fabre dedicate a level of investment to R&D that places them in the middle bracket of the industry: 14.5 % of pharmaceutical net sales in 2018 where 50 % is allocated to oncology, mainly solid tumors, notably cancers of the aerodigestive tract such as colon cancer, head and neck cancers, or cancers of the urogenital tract, such as bladder cancer, as well as skin cancers (melanomas) and certain blood cancers such as leukemia.
How to apply
If the position sounds interesting to you, please send your application, including cv with your contact details, directly to the contact persons below.
Welcome with your application!